Jan. 30, 2021 – “Our findings suggest that higher storefront cannabis dispensary counts are associated with reduced opioid-related mortality rates at the county level,” the authors write. “While the associations documented cannot be assumed to be causal, they suggest a potential association between increased prevalence of medical and recreational cannabis dispensaries and reduced opioid-related mortality rates.” The study by Greta Hsu, at the University of California, Davis, and Balázs Kovács, at Yale University, was published this week in The BMJ, a respected medical journal previous known as the British Medical Journal. It follows a Canadian study published this week that found legalizing cannabis led to a “marked decline” in the volume of opioids prescribed across Canada.



Subscribe Today! Your best source of current news, information and opinion about the issues that matter to you most. Serving the treatment industry, recovery community and health and wellness professionals.